TGF-beta gene expression depends on tissue architecture.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Effects of culture condition on epigenomic profiles of brain tumor cells.ACS biomaterials science & engineering · 2019
   Article
2. Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontin.Journal of cellular and molecular medicine · 2010
   Article
3. Complex role of tumor cell transforming growth factor (TGF)-beta s on breast carcinoma progression.Journal of mammary gland biology and neoplasia · 1996
   Review
4. Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogene expression.The Journal of cell biology · 1995
   Article
5. Drug and radiation resistance in spheroids: cell contact and kinetics.Cancer metastasis reviews · 1994
   Review
6. Growth advantage ("clonal dominance") of metastatically competent tumor cell variants expressed under selective two- or three-dimensional tissue culture conditions.In vitro cellular & developmental biology. Animal · 1993
   Article
7. Acquired multicellular-mediated resistance to alkylating agents in cancer.Proceedings of the National Academy of Sciences of the United States of America · 1993
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as